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Hemoglobinopathies are among the most common inherited diseases around the world and are one of the world’s major health problems. They are monogenic 
diseases of autosomal recessive transmission resulting from mutations affecting the genes responsible for the synthesis of globin chains.  Abnormal hemoglobins 
(Hb), named Hb variants, are caused by structural defects resulting from an altered amino acid sequence in globin chains, being Hb S the more frequent and 
pathogenic/disease associated.  
Hemoglobinopathies are unique among all genetic diseases where carriers detection is possible by hematological and biochemical tests. However, identification of 
Hb variants by these methodologies is often presumptive, based on migration patterns and retention times, and should be based on a minimum of two techniques 
with different principles. Also, the analytical procedures employed should be able to detect all the common clinically significant hemoglobin variants: Hb S, Hb C, Hb 
DPunjab , Hb E and Hb OArab. Nevertheless, in complex cases or when the hematological/biochemical results are unclear, definitive identification requires DNA 
analysis, mass spectrometry or protein sequencing1, 2. 
The aim of this work was to identify and characterize Hb variants with mobility similar to Hb S when using common 
laboratorial methodologies, such as isoelectric focusing and high pressure ion exchange chromatography (HPLC). 
Hemoglobin analysis was performed by isoelectric focusing (IEF) and Ion Exchange High Performance Liquid 
Chromatography (HPLC). Globin chain variants were classified in alpha or beta type by Reversed Phase High 
Performance Liquid Chromatography (RP-HPLC).  Hb S was confirmed by the Sickle Solubility Test (TS). In order 
to identify the rare Hb variants, molecular analysis was performed in patient’s DNA. 
[1] Ryan K. et al. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br. J. Haematol., 2010, 149: 35-49.  
[2] Traeger-Synodinos J. et al. EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies. Eur. J. Hum. Genet., 2015.  23: 426-37.  
(3] Globin Gene Server (http://globin.bx.psu.edu/cgi-bin/hbvar/counter 
Results and discussion 
From 2010 to 2016, in the routine practice of our laboratory, 601 cases of variants of Hb were detected with mobility Hb S-like. Amongst them, 433 were confirmed 
as being Hb S (72.0%). Others hemoglobins also with clinical relevance, Hb D and Hb Lepore, were prevalent, 90 (15.0%) and 61 (10.2%), respectively. The 
remaining 17 cases were classified as rare (2.8%) and 10 of them were  identified by molecular studies as: Hb Maputo, Hb G-Coushatta, Hb Summer Hill, Hb Setif, 
Hb G Waimanalo, Hb D Iran, Hb Oleander, Hb Ottawa, Hb Etobicoque and Hb Matsue-Oki (Figure 1 and Table 1). Hb Matsue-Oki was found in compound 
heterozygosity with the –α3.7kb-thalassemia deletion. 
The presumptive identification of Hb S , Hb D and Hb Lepore was based on migration patterns of IEF and retention times of exchange ionic HPLC of hemoglobins 
as well as the result of sickle solubility test and chromatographic behavior of reversed phase HPLC globin chains (Figure 2). Rare hemoglobin variants were 
characterized by our used methodologies and identified by DNA analysis (Figure 3 and 4). 
We can conclude that combining the results obtained by the different biochemical methodologies allow the presumptive identification of the more prevalent 
variants, namely Hb S, Hb D and Hb Lepore, and direct the molecular study for the definitive identification. This study also revealed that several rare 
variants have similar mobility as Hb S and, consequently, some safety measures should be applied in order to achieve their accurate identification. A 
correct laboratorial diagnosis is essential for proper patient’s clinical management and genetic counselling.  
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Table 1 - Biochemical  and molecular characteristics of rare variants with electrophoretic mobility like HbS 
Presumptive Identification  
Isoelectric focusing  Mobility similar to Hb S 
Sickle solubility test  Negative  
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 Peak in the HbS  
window  
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window 
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globin chains  
β-chain Hb 
variant 
β-chain Hb 
variant 
β-chain Hb 
variant 
β-chain Hb 
variant 
α-chain Hb 
variant 
α-chain Hb 
variant 
α-chain Hb  
variant 
Silent  Silent  Silent  
Definitive Identification  
Molecular biology  
Hb Maputo 
Hb G-
Coushatta 
Hb Summer 
Hill 
Hb D-Iran  Hb Setif Hb Oleander Hb Etobicoque Hb Ottawa Hb Matsue-Oki 
Hb G-
Waimanalo 
HBB:c.142G>T  HBB:c.68A>C  HBB:c.157G>C HBB:c.67G>C HBA2:c.283G>T  HBA2:c.349G>C HBA2:c.255C>A HBA2:c.46G>C  HBA2:c.226G>A HBA2:c.193G>A 
Hemoglobin variants with eletrophoretic mobility similar to Hemoglobin S (2010-2016) 
  Hb S Hb D Hb Lepore DNA analysis Without DNA analysis 
No. of cases 433 90 61 10 7 
% 72.0 15.0 10.2 1.7 1.1 
Figure 1- Variants of Hb with mobility Hb S-like detected in our lab during 2000-2016: 433 Hb S, 90 Hb D, 61 Hb Lepore. The 
remaining 17 cases were classified as rare and 10 of them were  identified by molecular studies . 
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Figure 3- Biochemical characterization and molecular identification of rare beta chain hemoglobin 
variant,  Hb G-Coushatta a) Isoelectric focusing migration pattern b) Exchange ion chromatographic 
behaviour showing a   peak on Hb A2 window (40.3%) c) Reversed phase HPLC of globin chains, revealing 
the presence of abnormal β chain d) Partial electropherogram of the exon 1-HBB gene; heterozygosity for 
the variant: c.68A>C , p.Glu22Ala. 
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Figure 2- Results of different methodologies for presumptive identification of Hb S, Hb D and Hb Lepore. a) Isoelectric focusing migration 
pattern b) Peak on Hb S window (38.3%) by ion iexchange HPLC c) Sickle solubility test positive for Hb S d) Peak on Hb A2 window (11.6%) by 
ion exchange HPLC indicative of Hb Lepore e) Peak on Hb D window (37.3%) by ion exchange HPLC f) Reversed phase HPLC of globin 
chains, revealing the presence of βD chains and normal β chains. 
Figure 4- Biochemical characterization and molecular identification of rare alpha chain hemoglobin 
variant, Hb Matsue Oki a) Isoelectric focusing migration pattern b) Exchange ion chromatographic 
behaviour showing a peak on Hb S window (29.4%) c) Reversed phase HPLC of globin chains 
showing a normal elution pattern d) Partial electropherogram of the exon 2-HBA2 gene, hemizygosity 
for the variant: c.226G>A. p.Asp75Asn. 
a) 
 
d) 
b) 
c) 
C 
S 
F 
A 
C 
S 
F 
A 
